2,005
Participants
Start Date
April 22, 2020
Primary Completion Date
June 25, 2024
Study Completion Date
June 25, 2024
Prospective observational cohort study
Prospective observational cohort study
GSK Investigational Site, Xiamen
GSK Investigational Site, Qingyuan
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Shaoguan
GSK Investigational Site, Wengyuan
GSK Investigational Site, Meizhou
GSK Investigational Site, Shantou
GSK Investigational Site, Shantou
GSK Investigational Site, Jieyang
GSK Investigational Site, Huizhou
GSK Investigational Site, Huizhou
GSK Investigational Site, Heyuan
GSK Investigational Site, Heyuan
GSK Investigational Site, Shenzhen
GSK Investigational Site, Shenzhen
GSK Investigational Site, Shenzhen
GSK Investigational Site, Shenzhen
GSK Investigational Site, Shenzhen
GSK Investigational Site, Shenzhen
GSK Investigational Site, Zhuhai
GSK Investigational Site, Jieyang
GSK Investigational Site, Dongguan
GSK Investigational Site, Dongguan
GSK Investigational Site, Zhanjiang
GSK Investigational Site, Zhaoqing
GSK Investigational Site, Yunfu
GSK Investigational Site, Foshan
GSK Investigational Site, Foshan
GSK Investigational Site, Foshan
GSK Investigational Site, Shunde
GSK Investigational Site, Zhangshan
GSK Investigational Site, Zhangshan
GSK Investigational Site, Jiangmen
GSK Investigational Site, Jiangmen
Lead Sponsor
Guangzhou Institute of Respiratory Health (GIRH)
UNKNOWN
GlaxoSmithKline
INDUSTRY